Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Childhood Acute Lymphoblastic Leukemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Acute lymphoblastic leukemia, excluding known mature B-cell ALL~* \< 18 years of age~* Patients who are leukopheresed or exchanged are eligible for study only after completion of the pheresis or exchange transfusion~* Absence of a t(8,14) (q24; q32), t (8,22), t(2,8)~* Total bilirubin \< 1.4mg/dl~Exclusion Criteria:~* Known HIV positive~* Prior steroid therapy within 30 days of diagnosis~* Septic shock~* Ongoing intracranial hemorrhage~* Clinical evidence of CNS or lung leukostasis

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).